1. Home
  2. FWRD vs PRAX Comparison

FWRD vs PRAX Comparison

Compare FWRD & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forward Air Corporation

FWRD

Forward Air Corporation

HOLD

Current Price

$26.11

Market Cap

708.1M

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$291.85

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FWRD
PRAX
Founded
1981
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
708.1M
7.2B
IPO Year
1993
2020

Fundamental Metrics

Financial Performance
Metric
FWRD
PRAX
Price
$26.11
$291.85
Analyst Decision
Buy
Strong Buy
Analyst Count
4
14
Target Price
$34.33
$373.79
AVG Volume (30 Days)
401.1K
615.7K
Earning Date
02-25-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,496,734,000.00
$7,463,000.00
Revenue This Year
$3.18
N/A
Revenue Next Year
$4.39
$12,467.71
P/E Ratio
N/A
N/A
Revenue Growth
14.54
364.98
52 Week Low
$9.79
$26.70
52 Week High
$35.47
$317.72

Technical Indicators

Market Signals
Indicator
FWRD
PRAX
Relative Strength Index (RSI) 65.29 62.92
Support Level $25.12 $268.78
Resistance Level $26.29 $317.72
Average True Range (ATR) 0.68 13.98
MACD -0.09 -3.34
Stochastic Oscillator 85.15 50.94

Price Performance

Historical Comparison
FWRD
PRAX

About FWRD Forward Air Corporation

Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in the United States, Canada, and Mexico.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Share on Social Networks: